Literature DB >> 9661028

Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.

G P Moran1, D Sanglard, S M Donnelly, D B Shanley, D J Sullivan, D C Coleman.   

Abstract

Candida dubliniensis is a recently described Candida species associated with oral candidosis in human immunodeficiency virus (HIV)-infected and AIDS patients, from whom fluconazole-resistant clinical isolates have been previously recovered. Furthermore, derivatives exhibiting a stable fluconazole-resistant phenotype have been readily generated in vitro from fluconazole-susceptible isolates following exposure to the drug. In this study, fluconazole-resistant isolates accumulated up to 80% less [3H] fluconazole than susceptible isolates and also exhibited reduced susceptibility to the metabolic inhibitors 4-nitroquinoline-N-oxide and methotrexate. These findings suggested that C. dubliniensis may encode multidrug transporters similar to those encoded by the C. albicans MDR1, CDR1, and CDR2 genes (CaMDR1, CaCDR1, and CaCDR2, respectively). A C. dubliniensis homolog of CaMDR1, termed CdMDR1, was cloned; its nucleotide sequence was found to be 92% identical to the corresponding CaMDR1 sequence, while the predicted CdMDR1 protein was found to be 96% identical to the corresponding CaMDR1 protein. By PCR, C. dubliniensis was also found to encode homologs of CDR1 and CDR2, termed CdCDR1 and CdCDR2, respectively. Expression of CdMDR1 in a fluconazole-susceptible delta pdr5 null mutant of Saccharomyces cerevisiae conferred a fluconazole-resistant phenotype and resulted in a 75% decrease in accumulation of [3H]fluconazole. Northern analysis of fluconazole-susceptible and -resistant isolates of C. dubliniensis revealed that fluconazole resistance was associated with increased expression of CdMDR1 mRNA. In contrast, most studies showed that overexpression of CaCDR1 was associated with fluconazole resistance in C. albicans. Increased levels of the CdMdr1p protein were also detected in fluconazole-resistant isolates. Similar results were obtained with fluconazole-resistant derivatives of C. dubliniensis generated in vitro, some of which also exhibited increased levels of CdCDR1 mRNA and CdCdr1p protein. These results demonstrate that C. dubliniensis encodes multidrug transporters which mediate fluconazole resistance in clinical isolates and which can be rapidly mobilized, at least in vitro, on exposure to fluconazole.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661028      PMCID: PMC105690          DOI: 10.1128/AAC.42.7.1819

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Comparison of restriction enzyme analysis and pulsed-field gradient gel electrophoresis as typing systems for Candida albicans.

Authors:  J A Vazquez; A Beckley; J D Sobel; M J Zervos
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

3.  Genetic characterization of a phospholipase C gene from Candida albicans: presence of homologous sequences in Candida species other than Candida albicans.

Authors:  Désirée E Bennett; Christine E McCreary; David C Coleman
Journal:  Microbiology (Reading)       Date:  1998-01       Impact factor: 2.777

4.  Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.

Authors:  J R Wingard; W G Merz; M G Rinaldi; T R Johnson; J E Karp; R Saral
Journal:  N Engl J Med       Date:  1991-10-31       Impact factor: 91.245

5.  Candida dubliniensis: phylogeny and putative virulence factors.

Authors:  G D Gilfillan; D J Sullivan; K Haynes; T Parkinson; D C Coleman; N A Gow
Journal:  Microbiology (Reading)       Date:  1998-04       Impact factor: 2.777

6.  CLUSTAL: a package for performing multiple sequence alignment on a microcomputer.

Authors:  D G Higgins; P M Sharp
Journal:  Gene       Date:  1988-12-15       Impact factor: 3.688

7.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

8.  Azole drug resistance in yeasts.

Authors:  E M Johnson; D W Warnock
Journal:  J Antimicrob Chemother       Date:  1995-11       Impact factor: 5.790

9.  Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate.

Authors:  M E Fling; J Kopf; A Tamarkin; J A Gorman; H A Smith; Y Koltin
Journal:  Mol Gen Genet       Date:  1991-06

Review 10.  Genomic variation in C. albicans.

Authors:  B L Wickes; R Petter
Journal:  Curr Top Med Mycol       Date:  1996-12
View more
  55 in total

1.  Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals.

Authors:  M A Jabra-Rizk; W A Falkler; W G Merz; A A Baqui; J I Kelley; T F Meiller
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Growth competition between Candida dubliniensis and Candida albicans under broth and biofilm growing conditions.

Authors:  W R Kirkpatrick; J L Lopez-Ribot; R K McAtee; T F Patterson
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 3.  Antifungal activity of nonantifungal drugs.

Authors:  J Afeltra; P E Verweij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-26       Impact factor: 3.267

Review 4.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

5.  Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains.

Authors:  Sabrina Schubert; P David Rogers; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

6.  In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.

Authors:  M A Pfaller; S A Messer; S Gee; S Joly; C Pujol; D J Sullivan; D C Coleman; D R Soll
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Candida dubliniensis at a university hospital in Saudi Arabia.

Authors:  R Fotedar; S S A Al-Hedaithy
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Candida dubliniensis infections in a pediatric population: retrospective identification from clinical laboratory isolates of Candida albicans.

Authors:  Jean O Kim; Lucille Garofalo; Deborah Blecker-Shelly; Karin L McGowan
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Candida albicans AGE3, the ortholog of the S. cerevisiae ARF-GAP-encoding gene GCS1, is required for hyphal growth and drug resistance.

Authors:  Thomas Lettner; Ute Zeidler; Mario Gimona; Michael Hauser; Michael Breitenbach; Arnold Bito
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

Review 10.  Fungal biofilms and drug resistance.

Authors:  Mary Ann Jabra-Rizk; William A Falkler; Timothy F Meiller
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.